Archive for the ‘Health Policy’ Category

Luke
Dickinson

Decision 2012 – Presidential Candidates on Health Care

Tuesday, December 20th, 2011

Across early primary states Republican Presidential candidates are fighting tooth and nail to appeal to voters in the hope of becoming the next President of the United States of America.

While prime-time pundits may revel in polling data, “zany” tactics or the latest campaign trail gaffe, serious voters remain concerned with the issues. The economy has become the hot topic for the cycle, but with Democrat-led health care reforms still riling many Republicans, voters are paying close attention to the candidates’ stance on health care.

The overarching message from each and every candidate is dire need to “repeal Obamacare.” Republicans argue that “Obamacare,” the Affordable Care Act passed by President Obama in March of 2010, does little to improve health care quality while simultaneously restricting individual freedoms through requirements to purchase health insurance. If elected, each major Republican candidate would repeal “Obamacare.” But where will each candidate go from there?

(more…)

Tags: , , , ,

 
Luke
Dickinson

SCOTUS Beat: Review of Health Care Reform Heats Up

Friday, October 28th, 2011

The highly anticipated Supreme Court review of landmark health care reform legislation has taken a step closer to reality. The nine Supreme Court Justices announced on Oct. 26 that they will review five of six pending petitions on Nov. 10, one of their closed-door conference days.

In this session, the Justices will decide whether or not to hear any or all of the petitions that challenge the massive Patient Protection and Affordable Care Act (ACA), spearheaded by the Obama administration. While it is not guaranteed that the petitions will come before the court, legal experts anticipate that the Justices will take on this controversial topic, notably as lower federal appeals courts have previously made divergent rulings on the constitutionality of the new law.

So just what are these petitions? Four of the five to be reviewed on Nov. 10 are challenges to the ACA, with the fifth presented by the federal government to defend the constitutionality of key elements of the act. A sixth petition, which is not yet ready to be presented to the Justices, examines the rights of states, specifically Virginia, to challenge the federal government in court.

The most contentious element that the Court may decide is whether Congress exceeded its authority by mandating that virtually all Americans purchase health insurance by 2014. Also up for possible review is whether new Medicaid requirements place too great a strain on the states. Further, if the Justices rule that the individual mandate is indeed unconstitutional, they must determine whether this invalidates the entire ACA or whether parts of it can remain enacted.

The decision of the Court on whether or not to hear these cases could come very quickly, either the day of the conference or the following Monday, Nov. 14. If the Court does, as anticipated, decide to hear the cases, it is more than likely they will be heard in the current term, with possible oral arguments coming in March 2012, with a decision as early as June 2012.

Lawyers, law makers, health care providers and individual citizens will be waiting with baited breath for the decision of the Supreme Court Justices. There is a great deal at stake for all parties on the potential decision of the Court, from the rights of patients and providers to statewide Medicare and Medicaid budgets, and potentially even the outcome of the 2012 Presidential election. Rest assured, the Full Spectrum Blog will be tracking the court every step of the way to keep our readers up-to-date.

Tags: , , , ,

 
Luke
Dickinson

SCOTUS Beat: Health Care Reform Hits the Supreme Court

Thursday, October 6th, 2011

The October 2011 Term of the Supreme Court of the United States (SCOTUS) opened Monday October 3 and with it a host of potentially decisive arguments on health care reform (HCR). Several cases on the docket for the six month session cut to the roots of the legislation; everything from the logistical implementation of individual elements of HCR to the very constitutionality of the measures passed by President Obama.

The very first case heard in the session has been called the sleeping giant of the HCR debate: Douglas v. Independent Living Center of Southern California. In its most basic sense, the case reviews whether healthcare providers and patients have the right to sue a state following cuts to Medicaid reimbursement rates; however the implications are far greater.

(more…)

Tags: , , ,

 
Jamie
Kuchinski

HIV/AIDS in DC: 30 years and still a communications issue

Monday, June 27th, 2011

Last Tuesday I attended the Henry J. Kaiser Family Foundation panel discussion which took a long hard look at the HIV/AIDS epidemic in the U.S. The panel, “AIDS at 30,” celebrated the progress of the 30-year HIV/AIDS battle, but also questioned how to end AIDS once and for all. While there’s no simple solution, the panel members explored how Americans can prevent the disease from taking more lives and shaving years off the lives of others.

Before the panel discussion, Jeff Crowley, Director of the Office of National AIDS Policy, spoke about the government’s National HIV/AIDS Strategy’s (NHAS) current progress. Twenty-one million dollars has already been set aside for the NHAS and several departments are coordinating policies and operational plans to address the epidemic. This ambitious plan, only a year old, aims to:

  • Reduce new infections
  • Increase access to care
  • Improve health outcomes for people with HIV
  • Reduce HIV-related health disparities

… all by 2015.

(more…)

Tags: , , , , , ,

 
Ricki
McCarroll

FDA beats out European Counterpart in Oncology Drug Approval

Thursday, June 16th, 2011

The FDA is proving to be a top contender in the international space in its efforts to fight the battle on the Big C, yes we’re talking cancer.

Source: Friends of Cancer Research Study

A new study released online today by Friends of Cancer Research in Health Affairs reports that the U.S. Food and Drug Administration (FDA) has a faster approval rate for oncology drugs than their European counterpart agency, the European Medicines Agency (EMA).

The study was held over a seven year period beginning 2003 through 2010. Authors Samantha A. Roberts, Jeff D. Allen, and Ellen V. Sigal investigated 35 drugs going through approval process in both markets and compiled their results in an eight-page report complete with graphics and pull quotes.

FDA v. EMA Stats

  • 35 drugs were investigated
  • FDA approved 32 oncology drugs while the EMA approved only 26
  • In addition, FDA’s approval for said drugs was over 31 percent more time efficient that the EMA

Statistically speaking, the approval ratio is less than one.

Finding the data

Authors of the study utilized public data bases on the FDA and EMA websites to conduct their research. Drugs used in the study are direct oncology treatments, drugs related to “supportive care” such as pain relievers and anti-nausea medications were omitted in their findings.

Check it Out

The Friends of Cancer Research study is currently available online and will be available in the July issue of Health Affairs.

What’s the spark under the FDA?

Tags: , , , , ,

 
Frannie
Marmorstein

Lupus Advocates Take On the Hill

Tuesday, March 29th, 2011

Last week I had the opportunity to participate in the Lupus Research Institute’s Tell Congress Event on Captiol Hill. Lupus is an autoimmune disorder with an unknown cause that affects the skin, joints, kidneys and other organs and involves the immune system attacking healthy cells and tissue because it cannot tell the difference between normal and unhealthy substances.

I spent the afternoon lobbying on the Hill with a dozen Lupus advocates, meeting with senators and listening as advocates voiced their concerns about Lupus awareness and increasing funding for lupus research. Advocates strived to make an impact by sharing with their senators their personal connections with the disease. Patients shared their difficulties living with chronic fatigue and joint pain, family members honored those they had lost to Lupus and caregivers, including children, discussed the hardship of caring for a parent with Lupus. Everyone had a story to share.

(more…)

Tags: , , ,